ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesF13.288

F13.288

Billable

Sedative, hypnotic or anxiolytic dependence with other sedative, hypnotic or anxiolytic-induced disorder

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 F13.288 is a billable code used to indicate a diagnosis of sedative, hypnotic or anxiolytic dependence with other sedative, hypnotic or anxiolytic-induced disorder.

Key Diagnostic Point:

F13.288 refers to a condition characterized by a dependence on sedative, hypnotic, or anxiolytic substances, accompanied by other disorders induced by these substances. Patients with this diagnosis often exhibit a compulsive pattern of use, leading to significant impairment or distress. The dependence may manifest through withdrawal symptoms when the substance is reduced or discontinued, as well as tolerance, where increasing amounts are needed to achieve the desired effect. Additionally, individuals may experience other induced disorders such as mood disturbances, cognitive impairments, or behavioral changes directly related to the use of these substances. Treatment typically involves a combination of medical detoxification, psychotherapy, and support groups, focusing on both the dependence and any co-occurring mental health disorders. Accurate coding is essential for appropriate treatment planning and insurance reimbursement.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Differentiating between dependence and intoxication
  • Identifying co-occurring mental health disorders
  • Documenting withdrawal symptoms accurately
  • Understanding the nuances of substance-induced disorders

Audit Risk Factors

  • Inadequate documentation of substance use history
  • Failure to document withdrawal symptoms
  • Misidentification of induced disorders
  • Lack of comprehensive treatment plans

Specialty Focus

Medical Specialties

Psychiatry

Documentation Requirements

Detailed patient history, including substance use patterns and mental health evaluations.

Common Clinical Scenarios

Patients presenting with anxiety disorders who misuse anxiolytics or those with insomnia using sedatives.

Billing Considerations

Consideration of comorbid mental health conditions and the impact on treatment efficacy.

Addiction Medicine

Documentation Requirements

Comprehensive assessment of substance use, including frequency, quantity, and impact on daily functioning.

Common Clinical Scenarios

Patients undergoing detoxification or those in outpatient treatment programs.

Billing Considerations

Integration of behavioral therapies and monitoring for relapse.

Coding Guidelines

Inclusion Criteria

Use F13.288 When
  • According to ICD
  • 10 guidelines, F13
  • 288 should be used when there is clear evidence of dependence on sedatives, hypnotics, or anxiolytics, along with documented induced disorders
  • Proper documentation of the patient's clinical status and treatment plan is essential

Exclusion Criteria

Do NOT use F13.288 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

H0031CPT Code

Mental health assessment

Clinical Scenario

Used during initial evaluations for patients with substance dependence.

Documentation Requirements

Comprehensive assessment notes including history and current status.

Specialty Considerations

Psychiatric evaluations should include substance use history.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of substance use disorders, enabling better tracking of treatment outcomes and resource allocation for patients with F13.288.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of substance use disorders, enabling better tracking of treatment outcomes and resource allocation for patients with F13.288.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of substance use disorders, enabling better tracking of treatment outcomes and resource allocation for patients with F13.288.

Resources

Clinical References

  • •
    Substance Abuse and Mental Health Services Administration (SAMHSA)

Coding & Billing References

  • •
    Substance Abuse and Mental Health Services Administration (SAMHSA)

Frequently Asked Questions

What is the difference between F13.288 and F13.280?

F13.288 includes the presence of other sedative, hypnotic, or anxiolytic-induced disorders, while F13.280 is used when there are no additional induced disorders present.